China has been engaged in the R&D and manufacturing of semi-automatic coagulation analyzers for over a decade, and based on the data from the website of the NMPA, in 2024 and 2025 (as od 15 August), a total of 2 instruments from 2 manufacturers have obtained registration certificates...

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China. Latest news

GE today announced that it has completed its previously announced acquisition of BK Medical, a leader in advanced surgical visualization, from Altaris Capital Partners, LLC.

Drugs developed to treat AIDS and HIV could offer hope to patients diagnosed with the most common form of primary brain tumour.

FIND announced on Monday that it is investing $21 million in four companies to develop and launch point-of-care molecular diagnostic platforms for infectious diseases.

Overweight or obesity, an unfavorable distribution of fat in the body and the development of type 2 diabetes are often associated with a reduced effect of the hormone insulin in many organs, including the brain (insulin resistance).

Pfizer announced on Dec. 13, 2021 that it had entered into a definitive agreement to acquire Arena Pharmaceuticals, a clinical stage company specializing in therapies treating immuno-inflammatory diseases, for $6.7 billion dollars.

On 17 December 2021, with the support of the Chongqing Municipal Commission of Commerce and Chongqing Customs District P.R.China, QIAGEN China and An Great (AIT) entered into a strategic cooperation to establish the QIAGEN Chongqing Bonded Distribution Centre.

Roche announced on Friday that its Cobas SARS-CoV-2 Qualitative test has received CE marking for use with saliva samples.

Becton Dickinson announced on Friday that it has received the CE-IVD mark for a new instrument component of its BD Cor system.

Roche announced on Wednesday that four of its molecular infectious disease tests for use on its new Cobas 5800 instrument have received CE marking.

When it comes to climate-friendly behaviour, there is often a gap between what we want and what we actually do. Although most people want to see climate change slowed down, many do not behave in an appropriately sustainable way.